resume writing services online biology as coursework help group project online graduate essay editing service term paper for sociology dissitation professional writing in nursing my childhood essay cheapest essays writing services

Catalogue of Services

What do LS RIs offer the life science community?

 

The 13 European Life Science Research Infrastructures (LS RIs) have the mission to support cutting-edge science by offering access to their resources and services to European scientists from academia and industry.

Resources and services can simply be consultation, access to experts, but also access to data and biological samples, use of data analysis tools, access to facilities (e.g. highly specialised microscopes) plus support from technicians and much more.

Some of these services are even free to use for institutions location in the RI's member states. 

 

The Catalogue of Services, which has been developed within the CORBEL project, is the first tool to list the main services of all LS RIs at a glance and it aims to facilitate the utilisation of RI services by researchers from all over the world. The Catalogue of Services as displayed below aims to provide you a basic overview on existing services within distinct thematic fields.

 

You can either use the Catalogue of Services to identify a single RI to help you with your work or you can create a service pipeline, i.e. using several RIs simultaneously.

What’s your need?

Please select…

EATRIS-ERIC

Contact person(s): Anne-Charlotte Fauvel

EATRIS supports researchers in translating their findings into novel interventions including preventive, diagnostic or therapeutic products up to clinical proof of concept. The infrastructure comprises over 90 leading research institutions in the translational field located in 13 countries across Europe. EATRIS also supports the validation and development of novel tools for precision medicine and translational research in drug development. By providing access to accredited facilities as well as market-oriented expertise, including innovation management, regulatory and health-technology assessment, your validation needs are covered in a one-stop shop.

Services provided

Services offered by EATRIS include

  • support funding applications (Identification of partners for consortium building, assessment of the project plan's impact and innovation potential)
  • translational research facilities and expertise for development of novel biomarkers, diagnostics and therapeutics
  • molecular, functional & hybrid imaging technologies, preclinical models, samples, patient cohorts, GMP manufacturing
  • regulatory and Health Technology Assessment (HTA) expertise
  • advice on intellectual property issues and industry partnering strategy (innovation management)

Costs

Costs are calculated on a case by case basis depending on the service required; some services can also be provided as part of funding proposals with EATRIS joining consortia as partner or subcontractor.
For further information please contact us.

Access modes

Services performed can be offered either centrally by the coordination and support team based in Amsterdam or remotely by the EATRIS institutions.

Why work with us

Translating novel biology insights into effective interventions or medical applications is a highly complex process. It requires significant dedicated expertise, facilities and resources. We believe in your medical innovation and we want to support you by bringing together the multi-disciplinary expertise and infrastructure required for optimising your translational trajectory. Working with EATRIS gives greater confidence in the translational feasibility of your project and its impact.

Countries involved

FR, NL, CZ, SE, NO, FI, IT, ES, SI, LU, LV, PO, BG

Services contact

Contact person(s): Anne-Charlotte Fauvel

About

EATRIS, the European infrastructure for translational medicine, provides high quality services in early development of novel therapeutics and diagnostics. Translational research is defined as research that develops promising biomedical innovations 'from bench to bedside,' and conversely brings clinical insights from bedside back to bench.

Translational research is a highly multi-disciplinary and complex undertaking. As a consequence, a major challenge in developing new innovations is understanding what steps need to be taken, and what expertise and technologies are suitable to perform these steps. External researchers in need for academic support will find that EATRIS is able to provide guidance by means of regulatory, clinical and technological expertise available within the infrastructure. Subsequently, EATRIS will match the need with the capabilities within the infrastructure and facilitate collaboration among academics and between academics and companies.

Biomedical inventions frequently fail to pass the “valley of death” for various reasons. EATRIS aims to overcome translational challenges by (1) developing new enabling technologies within the consortium, and (2) making high quality services available for other researchers.

EATRIS strives to accelerate medicines and diagnostics development by utilising cutting-edge, enabling technologies in early translational research. Academic researchers, companies and charities can access clinical expertise and high-end facilities that are available within the 80 top-tier academic centres across Europe comprising EATRIS. Member institutions are selected on the basis of their track record in public-private collaboration in translational development and their multidisciplinary teams of leading academic experts, high-end research facilities, production laboratories and licenses.

We focus on preclinical and early clinical development of drugs, vaccines and diagnostics. Solutions are provided in the fields of advanced therapy medicinal products, biomarkers, imaging and tracing, small molecules and vaccines.

The wide-ranging services portfolio focuses on supporting early decision-making and de-risking of projects. Examples include validation and development of in vitro and in vivo biomarkers for patient stratification, molecular imaging tracers for drug development programmes, GMP manufacturing of cellular therapy products, patient-derived xenograft models, and many more highly specialised capabilities.

General contact

Website: eatris.eu

Contact person(s): Anton Ussi

EMPHASIS

Contact person(s): Dr. Roland Pieruschka, Dr. Sven Fahrner

EMPHASIS is a pan-European, distributed plant phenotyping infrastructure. EMPHASIS will focus on developing and enabling access to plant phenotyping infrastructure and provision of services essential for the analysis of crop performance with respect to structure, function, quality and interaction with the environment. It will thus support the exploitation of crop genetic diversity required for the enhancement of plant productivity and progress in plant breeding.

Services provided

In cooperation with EPPN2020, EMPHASIS offers access to plant phenotyping infrastructures, which includes

  • high-throughput facilities
  • lean field facilities
  • intensive field facilities
  • assay development
  • data management

Further services are currently under development and will be implemented in its operational phase.

Costs

The access provided currently via EPPN2020 is free of charge for selected user-groups, based on a simple application procedure and includes the logistical, technological and scientific support as well as specific training required to successfully complete the approved Transnational Access project.
For further information please contact us.

Access modes

European-wide access to plant phenotyping infrastructures is currently under development in our partner project EPPN2020 and is provided via its homepage.

Access will be accordingly provided by EMPHASIS once it reaches its operational phase.

Why work with us

EPPN2020 provides transnational access to plant phenotyping infrastructure as a basis for novel scientific approaches to quantitative plant assessment in high throughput. The installations represent a diverse set of facilities for plant phenotyping in Europe with focus on: i) non-invasive high-throughput phenotyping under controlled conditions, ii) destructive sampling aiming at assessing underlying traits helping to understand the genetic variability of different plant processes, iii) controlled field facilities allowing users to control rainfall and/or the concentration of air CO2 together with high-definition, non-invasive sensors. Transnational access will be available based on a simple and transparent access procedure.

Countries involved

Preparatory Phase of the project: BE, FR, IT, NL, UK, DE

Services contact

Contact person(s): Dr. Roland Pieruschka, Dr. Sven Fahrner

About

EMPHASIS is a pan-European distributed plant phenotyping infrastructure project. EMPHASIS will focus on developing and enabling access to plant phenotyping infrastructure and provision of services, essential for the analysis of crop performance with respect to structure, function, quality and interaction with the environment. It will thus support the exploitation of crop genetic diversity required for the enhancement of plant productivity and progress in plant breeding.

Plant derived products are at the centre of grand challenges posed by increasing requirements for food, feed and bio-based raw materials. Integrating approaches across all scales from molecular to field applications are necessary to develop sustainable plant production with higher yield and at the same time using limited resources. While significant progress has been made in molecular and genetic approaches in recent years, the quantitative analysis of plant performance has become the major bottleneck. The challenge is to address multi-scale phenotyping for analysing genotype performance under diverse environmental conditions and quantify the diversity of traits contributing to performance, i.e. plant architecture, major functions, yield components and quality. Improvement of plant performance under changing climates requires the use of different categories of infrastructure combined with a coordinated infrastructure for storing and analysing data, and platforms for plant/crop modelling associated with phenotyping platforms.

Thus, plant phenotyping focuses on development and implementation of non-invasive technology, which can be used beyond plant sciences in disciplines such as image analysis, remote sensing or automation engineering. Additionally, plant phenotyping produces a number of data relevant for basic understanding in life sciences and practical breeding.

General contact

Website: emphasis.plant-phenotyping.eu

Contact person(s): emphasis(at)fz-juelich.de

ISBE

Contact person(s): Dr. Sonja Hansen, Prof. Gennaro Piccialli (Interim Coordinator), Anže Županic (ISBE.SI node), Alexey Kolodkin (ISBE.NL node)

ISBE empowers European researchers across academia, clinics and industry to implement systems biology approaches addressing how the dynamic interactions between biological components (molecules, cells, tissues, organs) leads to the functioning of living organisms. ISBE fosters project collaborations between experimental and computational teams, and with complementary research infrastructures. ISBE actively supports scientists in facilitating model-compliant data generation, making their research assets FAIR (i.e. findable, accessible, interoperable, and reusable) and creating predictive computational multi-scale models of biological systems based on integration of highly diverse data sets. In addition, ISBE will provide training for infrastructure users and providers to offer efficient services.

Services provided

Services offered by ISBE include

  • support to develop and exploit quantitative and predictive computational models to understand the functioning of complex biological systems
  • support in the acquisition of selected experimental data that are fit-for-modelling
  • model-based data integration and data analysis (e.g. cancer cell multiOMICS)
  • model analysis and validation
  • model-based simulation
  • support to implement tools and standards that make research assets FAIR (Findable, Accessible, Interoperable and Reusable) through the FAIRDOM organisation
  • training and education

Costs

The costs depend on the kind of service requested. All web-based services and simple advice by ISBE personnel is free; more extensive support is project based.
For further information please contact us.

Access modes

Access can be on-site or remote, depending on the kind of service requested.
For further information please contact us.

Why work with us

Systems biology is a branch of the life sciences that helps to obtain in-depth understanding through integrating multiple and diverse data sets in quantitative computational models. These models are able to predict the behaviour of biological systems based on experimental data about the interplay of molecules, cells and tissues in time and space. Validation and analysis of such predictions improve the model and gives insight into the interplay of system components in time and space. The success of this approach is illustrated with a number of examples.

Countries involved

Italy - ISBE Italy

Slovenia - ISBE Slovenia

Netherlands - ISBE@NL 

About

ISBE – Infrastructure for Systems Biology Europe – is a coordination effort to interconnect the best experimental and modeling facilities for Systems Biology in Europe. An ESFRI project, ISBE provides stewardship and insight into biological data and their acquisition: it is a research infrastructure that empowers European researchers across academia, clinics and industry to implement systems biology approaches addressing how the dynamic interactions between biological components (molecules, cells, tissues, organs) lead to the functioning of living organisms.

It is composed of three national candidate nodes, ISBE Netherlands, ISBE Slovenia, and ISBE Italy, and a project, FAIRDOM. Each node provides different services to the user community and has its own budget, but ISBE Italy is in charge of the interim coordination of ISBE Europe.

Please note: Most of the RIs are constantly developing their portfolio of services, so if you do not find the service/tool you are looking for, do not hesitate to contact the RI and ask for it!

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 654248.